A study to evaluate the efficacy of BCG vaccination in the treatment of multiple warts
Phase 4
- Conditions
- Health Condition 1: null- MULTIPLE WARTS
- Registration Number
- CTRI/2014/08/004834
- Lead Sponsor
- DR AVTAR KISHAN JAISINGHANI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Patient should have multiple warts (more than 2).
2.The age of the patient more than 17 years.
3.No concurrent systemic or topical treatment of warts
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of Participants with Clinical Resolution of Injected wart. When the participant completes the protocol, clinical resolution of the injected wart will be determined by the overall percentage of resolution from the initial visit. <br/ ><br>Complete response- 100% disappearance of warts. <br/ ><br>Partial response- 25-99% reduction in size. <br/ ><br>No response- 0-25% reduction in size.Timepoint: 5months
- Secondary Outcome Measures
Name Time Method umber of Participants with Clinical Resolution of Non-injected Wart. When the participant completes the protocol, clinical resolution of anatomically distant, non-injected wart will be determined by the overall percentage of resolution from the initial visit.Timepoint: 5months.